Search News Archives
Follow us on
Conferences | Events

Media Partners

 

BioFocus and Usher III Initiative, Inc. announce collaboration

BioFocus and the Usher III Initiative, Inc., a not-for-profit organization, announced today that they have embarked on a drug discovery project focused on Usher Syndrome Type III.  Usher Syndrome is a rare genetic disorder that causes the loss of hearing and vision.  Under the agreement, BioFocus will perform an integrated program encompassing medicinal chemistry and biological sciences.

"We are pleased to support the Usher III Initiative in its aim to find a targeted treatment and cure for Usher III," said Angus MacLeod, Vice President, Medicinal Chemistry, BioFocus. "This collaboration will utilize BioFocus' expertise in integrated drug discovery programs."

About Usher Syndrome

Three subtypes of Usher Syndrome have been identified as I, II and III.  The clinical symptoms and onset of the disease varies between the different subtypes: type I shows the most profound impact on hearing and vision, whereas type II and III are generally milder with onset occurring later in life.

About BioFocus

BioFocus aims to expand its partners' drug pipelines by accelerating the gene-to-clinical candidate discovery process. This is achieved through a comprehensive discovery platform, which includes target discovery in human primary cells, focused as well as diverse compound libraries, in vitro and cell-based screening, structural biology, medicinal chemistry, ADME/PK services, supported by unique chemogenomic and informatics tools, and compound library acquisition, storage and distribution services. As a service division of Galapagos BioFocus has over 250 employees based in the UK, the US and Switzerland. 

BioFocus® is a trademarks of Galapagos NV and/or its affiliates © Copyright 2010 Galapagos NV.


If you have not logged into the website then please enter your details below.



 


Popular this Month

 

Win a PIPETBOY from the new Integra summer collection!

 

Great Savings off Selected GC Columns

 

CytoSMART raises 5.2 million Euros for further product innovation and growth

 

High Volume Sample Storage in Space Efficient 96-Well Format

 

Cherwell Publishes Guide on Sterility Testing

 

Effective Removal of DMSO from Stored Samples

 

ATL Webcast: A Practical Guide to Selecting the Right LIMS

 

Genetic study reveals how gut bacteria work to keep us healthy

 

Lonza Establishes Custom Cell Biology Services to Offer Unique Manufacturing and Testing Capabilities

 

Thermo Fisher Scientific Opens Food Safety Customer Solution Center in India

 

 


 

 


 

Can't find what you are looking for?

Search by company or by product


Company Name:

Product:


 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd